Karyopharm Therapeutics Inc (KPTI) is a biotechnology company listed on US.
Latest reported KPTI revenue for 2026-06-30 was $68.5M. Net income was -$89.4M. Revenue was up 95.3% from 2026-03-31 to 2026-06-30. KPTI currently screens at market cap $205.6M.
Use this KPTI page for company research — sector, financials, and the latest filing takeaway — not a live tape. The session quote (last, range, volume) lives on the KPTI quote page. Cached 10-K, 10-Q, 8-K, and Form 4 exhibits are on the KPTI SEC filings page. Lician reads the product cache first so this HTML stays unique to Karyopharm Therapeutics Inc even when a live quote feed is slow.
Latest cached year on this hub. Full KPTI income, balance, and cash tables.